(Q37657039)

21 August 2017

1 reference

title

Novel aspects of complement in kidney injury (English)

1 reference

21 August 2017

Mark B Vieyra

1

1 reference

21 August 2017

Peter S Heeger

series ordinal

2

1 reference

21 August 2017

language of work or name

English

0 references

publication date

16 December 2009

1 reference

21 August 2017

1 reference

21 August 2017

volume

77

1 reference

21 August 2017

issue

6

1 reference

21 August 2017

page(s)

495-499

1 reference

Local synthesis of complement component C3 regulates acute renal transplant rejection

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.491

7 January 2021

Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.491

7 January 2021

Mechanisms of immune-deposit formation and the mediation of immune renal injury

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.491

7 January 2021

Complement regulatory genes and hemolytic uremic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.491

7 January 2021

The complement system in regulation of adaptive immunity

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.491

7 January 2021

Local extravascular pool of C3 is a determinant of postischemic acute renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.491

7 January 2021

New boundaries for complement in renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.491

7 January 2021

In situ localization of C3 synthesis in experimental acute renal allograft rejection

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.491

7 January 2021

Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.491

7 January 2021

C3a is required for the production of CXC chemokines by tubular epithelial cells after renal ishemia/reperfusion

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.491

7 January 2021

Gene silencing of complement C5a receptor using siRNA for preventing ischemia/reperfusion injury

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.491

7 January 2021

Pharmacological targeting of C5a receptors during organ preservation improves kidney graft survival.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.491

7 January 2021

Complement 5a receptor inhibition improves renal allograft survival

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.491

7 January 2021

Nontransgenic Hyperexpression of a Complement Regulator in Donor Kidney Modulates Transplant Ischemia/Reperfusion Damage, Acute Rejection, and Chronic Nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.491

7 January 2021

Synthesis of complement protein C3 in the kidney is an important mediator of local tissue injury

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.491

7 January 2021

C3a mediates epithelial-to-mesenchymal transition in proteinuric nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.491

7 January 2021

Decay-accelerating factor modulates induction of T cell immunity

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.491

7 January 2021

Decay accelerating factor can control T cell differentiation into IFN-gamma-producing effector cells via regulating local C5a-induced IL-12 production

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.491

7 January 2021

Locally produced C5a binds to T cell-expressed C5aR to enhance effector T-cell expansion by limiting antigen-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.491

7 January 2021

IFN-gamma and IL-17 production in experimental autoimmune encephalomyelitis depends on local APC-T cell complement production

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.491

7 January 2021

Donor deficiency of decay-accelerating factor accelerates murine T cell-mediated cardiac allograft rejection

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.491

7 January 2021

Primed CD8(+) T-cell responses to allogeneic endothelial cells are controlled by local complement activation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.491

7 January 2021

Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4+ T cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.491

7 January 2021

Graft-derived complement as a mediator of transplant injury

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.491

7 January 2021

Focal and segmental glomerulosclerosis induced in mice lacking decay-accelerating factor in T cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.491

7 January 2021

Complement gene expression in human cardiac allograft biopsies as a correlate of histologic grade of injury

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.491

7 January 2021

Expression of complement components differs between kidney allografts from living and deceased donors

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.491

7 January 2021

Influence of donor C3 allotype on late renal-transplantation outcome.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.491

7 January 2021

C3 polymorphisms and allograft outcome in renal transplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.491

7 January 2021

Eculizumab for paroxysmal nocturnal haemoglobinuria

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.491

7 January 2021

Identifiers

DOI

10.1038/KI.2009.491

1 reference

Dimensions Publication ID

21 August 2017

1042038653

0 references

1 reference